39 related articles for article (PubMed ID: 37183556)
1. Sirolimus for the treatment of patients with refractory connective tissue disease-related thrombocytopenia: a pilot study.
Du H; Su W; Su J; Hu J; Wu D; Long W; Zhu J
Rheumatology (Oxford); 2024 Jan; 63(1):79-84. PubMed ID: 37079730
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the clinical manifestations and hematological parameters associated with secondary immune thrombocytopenia in patients with primary Sjögren syndrome: An observational study.
Yang W
Medicine (Baltimore); 2024 May; 103(19):e37909. PubMed ID: 38728456
[TBL] [Abstract][Full Text] [Related]
3. Nomogram Based on Inflammatory Factor to Predict Therapeutic Response of Thrombocytopenia in Patients with Primary Sjögren's Syndrome.
Gan M; Peng Y; Zhu M; Ying Y
J Inflamm Res; 2023; 16():2449-2459. PubMed ID: 37334345
[TBL] [Abstract][Full Text] [Related]
4. Hyperglobulinemia predicts increased risk of mortality in primary Sjögren's syndrome: Based on a Chinese multicentre registry.
Zhong H; Wang Y; Yang P; Duan X; Wang Y; Xu J; Wu L; Li Q; Kong X; Zhang L; Li X; Xu D; Li M; Zhao Y; Zeng X
Mod Rheumatol; 2023 Dec; 34(1):137-143. PubMed ID: 36688590
[TBL] [Abstract][Full Text] [Related]
5. Decreased Expression of IL-35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia.
Cai X; Gui RY; Wu J; Wang CC; Zhu XL; Fu HX; Zhang XH
Adv Sci (Weinh); 2024 Mar; 11(12):e2305798. PubMed ID: 38225757
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of eltrombopag in connective tissue disease patients with refractory immune thrombocytopenia: a retrospective study.
Jiang X; Shu X; Ge Y
Rheumatol Adv Pract; 2024; 8(2):rkae029. PubMed ID: 38495431
[TBL] [Abstract][Full Text] [Related]
7. Morphologic evaluation of megakaryocytes in immune thrombocytopenia patients older than 80 years.
Demirci U; Umit EG; Baysal M; Demir AM
North Clin Istanb; 2023; 10(4):477-783. PubMed ID: 37719257
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and prognosis of thrombocytopenia in people living with HIV/AIDS.
Lv X; Li P; Yue P; Tang P; Zhou F
Ther Adv Hematol; 2023; 14():20406207231170513. PubMed ID: 37223778
[TBL] [Abstract][Full Text] [Related]
9. Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia.
Mashhadi MA; Kaykhaei MA; Sepehri Z; Miri-Moghaddam E
Daru; 2012 Aug; 20(1):7. PubMed ID: 23351609
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and treatment responses of immune thrombocytopenia in patients with primary Sjögren syndrome.
Sun F; Tang Q; Cheng W; Xie X; Li F; Chen J
Int Immunopharmacol; 2023 Oct; 123():110716. PubMed ID: 37506503
[TBL] [Abstract][Full Text] [Related]
11. Bone Marrow Megakaryocytes May Predict Therapeutic Response of Severe Thrombocytopenia in Patients with Systemic Lupus Erythematosus.
Zhao L; Xu D; Qiao L; Zhang X
J Rheumatol; 2016 Jun; 43(6):1038-44. PubMed ID: 27134253
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus therapy in primary Sjögren's syndrome with refractory immune thrombocytopenia: a retrospective study.
Xu R; Yan Q; Gong Y; Cai CS; Wu J; Yuan XY; Long XM
Clin Exp Rheumatol; 2022 Dec; 40(12):2268-2274. PubMed ID: 36135951
[TBL] [Abstract][Full Text] [Related]
13. Eltrombopag in severe immune thrombocytopenia secondary to connective tissue disease: a report of 17 patients and literature review.
Li W; Wang D; Ma L; Zhu Y; Wang F; Hua B; Wang H; Feng X
Clin Rheumatol; 2023 May; 42(5):1451-1457. PubMed ID: 36593363
[TBL] [Abstract][Full Text] [Related]
14. The role of the bone marrow examination in the diagnosis of immune thrombocytopenic purpura: case series and literature review.
Jubelirer SJ; Harpold R
Clin Appl Thromb Hemost; 2002 Jan; 8(1):73-6. PubMed ID: 11991243
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of bone marrow megakaryocyte count for immunotherapeutic response in primary Sjögren's syndrome patients with severe immune thrombocytopenia: A single-center case-control study in China.
Zhong H; Xue Y; Zhang L; Yang Y; Zhou J; Zhang S; Jiang N; Qiao L; Peng L; Wang L; Zhang W; Xu D; Li M; Zhao Y; Zeng X
Int J Rheum Dis; 2023 Jul; 26(7):1260-1267. PubMed ID: 37183556
[TBL] [Abstract][Full Text] [Related]
16. [Marrow megakaryocyte count as a response predictor of severe thrombocytopenia in patients with primary Sjögren syndrome].
Xue Y; Xu D; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):282-287. PubMed ID: 30917421
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
